Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease

  1. Jane A. Driver, MD, MPH1,
  2. Ashley Smith, MS1,
  3. Julie E. Buring, SCD1234,
  4. J. Michael Gaziano, MD, MPH125,
  5. Tobias Kurth, MD, SCD123 and
  6. Giancarlo Logroscino, MD, PHD13
  1. 1Division of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  2. 2Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
  3. 3Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
  4. 4Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Massachusetts
  5. 5Massachusetts Veterans Epidemiology Research Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts
  1. Corresponding author: Tobias Kurth, tkurth{at}rics.bwh.harvard.edu

Abstract

OBJECTIVE—To evaluate the association between type 2 diabetes and newly reported Parkinson's disease.

RESEARCH DESIGN AND METHODS—Our study included 21,841 participants in the Physicians’ Health Study, a cohort of U.S. male physicians. Diabetes and Parkinson's disease were self-reported via questionnaire. We used time-varying Cox regression to calculate adjusted relative risk (RR) for Parkinson's disease.

RESULTS—Over 23 years, 556 individuals with Parkinson's disease were identified. Subjects with diabetes had an increased Parkinson's disease risk (multivariable-adjusted RR 1.34 [95% CI 1.01–1.77]). The association remained significant after exclusion of those with known vascular disease. The diagnosis of diabetes was clustered around the diagnosis of Parkinson's disease and was more apparent among men with short diabetes duration and those without complications from diabetes.

CONCLUSIONS—Results of this large prospective study in men do not suggest that diabetes is a preceding risk factor for Parkinson's disease. Whether the positive association may be explained by ascertainment bias or a common underlying biological mechanism remains to be established.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 3 July 2008.

    Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted June 25, 2008.
    • Received April 9, 2008.
| Table of Contents

This Article

  1. Diabetes Care vol. 31 no. 10 2003-2005
  1. Online-Only Appendix
  2. All Versions of this Article:
    1. dc08-0688v1
    2. 31/10/2003 most recent